Skip to main content
Journal cover image

Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy

Publication ,  Conference
Denardo, JS; Davis, KE; Tcheng, JE
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
March 3, 2004

Duke Scholars

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

March 3, 2004

Volume

43

Issue

5

Start / End Page

31A / 31A

Location

New Orleans, LA

Publisher

ELSEVIER SCIENCE INC

Conference Name

54th Annual Scientific Session of the American-College-of-Cardiology

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Denardo, J. S., Davis, K. E., & Tcheng, J. E. (2004). Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 43, pp. 31A-31A). New Orleans, LA: ELSEVIER SCIENCE INC.
Denardo, J. S., K. E. Davis, and J. E. Tcheng. “Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 43:31A-31A. ELSEVIER SCIENCE INC, 2004.
Denardo JS, Davis KE, Tcheng JE. Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2004. p. 31A-31A.
Denardo, J. S., et al. “Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 43, no. 5, ELSEVIER SCIENCE INC, 2004, pp. 31A-31A.
Denardo JS, Davis KE, Tcheng JE. Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2004. p. 31A-31A.
Journal cover image

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

March 3, 2004

Volume

43

Issue

5

Start / End Page

31A / 31A

Location

New Orleans, LA

Publisher

ELSEVIER SCIENCE INC

Conference Name

54th Annual Scientific Session of the American-College-of-Cardiology

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology